PGS > Process

Genesis-24: The Technology & The Process

Genesis-24 screening is typically prescribed for couples of advanced maternal age, known familial translocations/inversions, gene duplications, and deletions, or families who have had recurrent pregnancy losses both naturally and through IVF.

Genesis-24 aims at improving pregnancy rate by testing your embryos for chromosome abnormalities—an increasing problem for families who choose to have children later in life. Without Genesis-24, embryos are chosen based on their visual quality and morphology alone. In cycles that incorporate Genesis-24, embryos are further assessed based on their chromosome compliment. Embryos with the normal number of chromosomes are more likely to result in pregnancy that is carried to term. Our rapid, accurate and confidential testing allows our patients to have fresh embryo transfers with the peace of mind that their embryos are chromosomally normal on day one of their pregnancy.

Genesis-24 screening utilizes the most sophisticated and scientifically validated technology for determining the chromosome compliment in a cell. Comparative Genomic Hybridization (CGH) is a microarray technology that compares the DNA in the embryo sample to a known normal control using tens of thousands of genetic markers throughout the human genome. Data is obtained which results in a computer-generated chromosome map for each embryo sample. Our trained scientists interpret the data and provide a detailed genetic report to your IVF physicians in time for your embryo transfer.

This technology is the standard around Europe and the U.S.A. and the only technology accepted by the European Society of Human Reproduction and Embryology (ESHRE).

To learn more, email one of our Genetic Counselors here.

Check This Out...

 Join Us on Facebook!